Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Operating expenses
Research and development	$ 6,645,417	$ 4,209,981
General and administrative	10,620,008	7,224,252
Total operating expenses	17,265,425	11,434,233
Operating loss	(17,265,425)	(11,434,233)
Other income	25,648	29,299
Loss before income taxes	(17,239,777)	(11,404,934)
Income taxes	0	0
Net loss	(17,239,777)	(11,404,934)
Deemed dividend attributable to preferred stock		(11,479,308)
Net loss applicable to common shareholders	$ (17,239,777)	$ (22,884,242)
Loss per common share - basic and diluted (in dollars per share)	$ (2.03)	$ (5.50)
Weighted average shares outstanding - basic and diluted (in shares)	8,496,964	4,157,746